Atlas Trials

Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis

Clinical trial NCT02353039 · UNKNOWN

Trial details

NCT number
NCT02353039
Sponsor
Green Cross Corporation
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastritis
Start date
2014-09-01
Primary completion
2015-07-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.